Abstract
Protein kinase C (PKC) activation by a phorbol ester increases myosin light chain (MLC20) phosphorylation through inhibition of MLC phosphatase (MLCP) and enhances contraction of vascular smooth muscle. We investigated whether Rho kinase, which is known to inhibit MLCP, is involved in the MLC20 phosphorylation caused by a phorbol ester, 12-deoxyphorbol 13-isobutyrate (DPB), in rabbit aortas. DPB (1 μM) increased MLC20 phosphorylation and tension. The Rho kinase inhibitor fasudil (10 μM) inhibited the DPB-induced contraction and decreased the MLC20 phosphorylation at Ser19, a site phosphorylated by MLC kinase, although it did not affect the phosphorylation of total MLC20. Rinsing a 65.4 mM KCl-contracted aorta with Ca2+-free, EGTA solution caused rapid dephosphorylation of MLC20 and relaxation. When DPB was present in the rinsing solution, the MLC20 dephosphorylation and the relaxation were inhibited. In this protocol, Ro31-8220 (10 μM), a PKC inhibitor, suppressed the phosphorylation of total MLC20 and Ser19 induced by DPB. Fasudil also inhibited the Ser19 phosphorylation to a degree similar to Ro31-8220 and accelerated relaxation, which was less than the relaxation caused by Ro31-8220. The phospholipase A2 inhibitor ONO-RS-082 (5 μM) inhibited the DPB-induced Ser19 phosphorylation but only transiently decreased the tension, suggesting the involvement of arachidonic acid in the phosphorylation and the existence of a MLC20 phosphorylation-independent mechanism. When fasudil was combined with ONO-RS-082, fasudil exerted additional inhibition of the tension without further inhibition of the Ser19 phosphorylation. DPB phosphorylated the 130 kDa myosin binding subunit (MBS) of MLCP and fasudil inhibited the phosphorylation. These data suggest that the inhibition by fasudil of DPB-induced contraction and phosphorylation of MLC20 at the MLC kinase-targeted site is a result of inhibition of Rho kinase. Thus, the PKC-dependent Ca2+-sensitization of vascular smooth muscle involves Rho kinase. A MLC20 phosphorylation-independent mechanism is also involved in the Ca2+-sensitization.
Similar content being viewed by others
References
Araki S, Ito M, Kureishi K, Feng J, Machida H, Isaka N, Amano M, Kaibuchi K, Hartshorne DJ, Nakano T (2001) Arachidonic acid-induced Ca2+ sensitization of smooth muscle contraction through activation of Rho-kinase. Pflügers Arch 441:596–603
Asano M, Matsunaga K, Miura M, Ito KM, Seto M, Sakurada K, Nagumo H, Sasaki Y, Ito K (1995) Selectivity of action of staurosporine on Ca2+ movements and contractions in vascular smooth muscles. Eur J Pharmacol 294:693–701
Barany K, Polyak E, Barany M (1992) Involvement of calponin and caldesmon in sustained contraction of arterial smooth muscle. Biochem Biophys Res Commun 187:847–852
Earley JJ, Su X, Moreland RS (1998) Caldesmon inhibits active crossbridges in unstimulated vascular smooth muscle. An antisense oligodeoxynucleotide approach. Circ Res 83:661–667
Feng J, Ito M, Kureishi Y, Ichikawa K, Amano M, Isaka N, Okawa K, Iwamatsu A, Kaibuchi K, Hartshorne DJ, Nakano T (1999) Rho-associated kinase of chicken gizzard smooth muscle. J Biol Chem 274:3744–3752
Fu X, Gong MC, Jia T, Somlyo AV, Somlyo AP (1998) The effects of the Rho-kinase inhibitor Y-27632 on arachidonic acid-, GTPγS-, and phorbol ester-induced Ca2+-sensitization of smooth muscle. FEBS Lett 440:183–187
Gailly P, Gong MC, Somlyo AV, Somlyo AP (1997) Possible role of atypical protein kinase C activated by arachidonic acid in Ca2+ sensitization of rabbit smooth muscle. J Physiol 500:95–100
Gong MC, Fuglsang A, Alessi D, Kobayashi S, Cohen P, Somlyo AV, Somlyo AP (1992) Arachidonic acid inhibits myosin light chain phosphatase and sensitizes smooth muscle to calcium. J Biol Chem 267:21492–21498
Gong MC, Kinter MT, Somlyo AV, Somlyo AP (1995) Arachidonic acid and diacylglycerol release associated with inhibition of myosin light chain dephosphorylation in rabbit smooth muscle. J Physiol 486:113–122
Hart MJ, Jiang X, Kozasa T, Roscoe W, Singer WD, Gilman AG, Sternweis PC, Bollag G (1998) Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Gα13. Science 280:2112–2114
Hartshorne DJ, Ito M, Erdodi F (1998) Myosin light chain phosphatase: subunit composition, interactions and regulation. J Muscle Res Cell Motil 19:325–341
Horowitz A, Menice CB, Laporte R, Morgan KG (1996) Mechanisms of smooth muscle contraction. Physiol Rev 76:967–1003
Ikebe M, Hartshorne DJ (1985) Phosphorylation of smooth muscle myosin at two distinct sites by myosin light chain kinase. J Biol Chem 260:10027–10031
Ikebe M, Hartshorne DJ, Ellzinga M (1987) Phosphorylation of the 20,000-dalton light chain of smooth muscle myosin by the calcium-activated, phospholipid-dependent protein kinase. Phosphorylation sites and effects of phosphorylation. J Biol Chem 262:9569–9573
Ito K, Shimomura E, Iwanaga T, Shiraishi M, Shindo K, Nakamura J, Nagumo H, Seto M, Sasaki Y, Takuwa Y (2003) Essential role of rho kinase in the Ca2+ sensitization of prostaglandin F2α-induced contraction of rabbit aortae. J Physiol 546:823–836
Itoh T, Suzuki A, Watanabe Y, Mino T, Naka M, Tanaka T (1995) A calponin peptide enhances Ca2+ sensitivity of smooth muscle contraction without affecting myosin light chain phosphorylation. J Biol Chem 270:20400–20403
Je H-D, Gangopadhyay SS, Ashworth TD, Morgan KG (2001) Calponin is required for agonist-induced signal transduction—evidence from an antisense approach in ferret smooth muscle. J Physiol 537:567–577
Kandabashi T, Shimokawa H, Miyata K, Kunihiro I, Kawano Y, Fukata Y, Higo T, Egashira K, Takahashi S, Kaibuchi K, Takeshita A (2000) Inhibition of myosin phosphatase by upregulated Rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1β. Circulation 101:1319–1323
Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng T, Okawa K, Iwamatsu A, Kaibuchi K (1996) Regulation of myosin phosphatase by Rho and Rho-associated kinase (rho-kinase). Science 273:245–248
Kitazawa T, Takizawa N, Ikebe M, Eto M (1999) Reconstitution of protein kinase C-induced contractile Ca2+ sensitization in Triton X-100-demembranated rabbit arterial smooth muscle. J Physiol 520:139–152
Kitazawa T, Eto M, Woodsome TP, Brautigan DL (2000) Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility. J Biol Chem 275:9897–9900
Koyama M, Ito M, Feng J, Seko T, Shiraki K, Takase K, Hartshorne DJ, Nakano T (2000) Phosphorylation of CPI-17, an inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase. FEBS Lett 475:197–200
Kozasa T, Jiang X, Hart MJ, Sternweis PM, Singer WD, Gilman AG, Bollag G, Sternweis PC (1998) p115 RhoGEF, a GTPase activating protein for Gα12 and Gα13. Science 280:2109–2111
Li L, Eto M, Lee MR, Morita F, Yazawa M, Kitazawa T (1998) Possible involvement of the novel CPI-17 protein in protein kinase C signal transduction of rabbit arterial smooth muscle. J Physiol 508:871–881
Masuo M, Reardon S, Ikebe M, Kitazawa T (1994) A novel mechanism for the Ca2+-sensitizing effect of protein kinase C on vascular smooth muscle: inhibition of myosin light chain phosphatase. J Gen Physiol 104:265–286
Miura M, Iwanaga T, Ito KM, Seto M, Sasaki Y, Ito K (1997) The role of myosin light chain kinase-dependent phosphorylation of myosin light chain in phorbol ester-induced contraction of rabbit aorta. Pflügers Arch 434:685–693
Nagumo H, Seto M, Sakurada K, Walsh MP, Sasaki Y (1998) HA1077, a protein kinase inhibitor, inhibits calponin phosphorylation on Ser175 in porcine coronary artery. Eur J Pharmacol 360:257–264
Nagumo H, Sasaki Y, Ono Y, Okamoto H, Seto M, Takuwa Y (2000) Rho kinase inhibitor HA-1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cells. Am J Physiol 278:C57–C65
Nakamura K, Nishimura J, Hirano K, Ibayashi S, Fujishima M, Kanaide H (2003) Hydroxyfasudil, an active metabolite of fasudil hydrochloride, relaxes the rabbit basilar artery by disinhibition of myosin light chain phosphatase. J Cereb Blood Flow Metab 21:876–885
Nishikawa M, Sellers JR, Adelstein RS, Hidaka H (1984) Protein kinase C modulates in vitro phosphorylation of the smooth muscle heavy meromyosin by myosin light chain kinase. J Biol Chem 259:8808–8814
Rokolya A, Walsh MP, Moreland RS (1996) Calcium- and phorbol ester-dependent calponin phosphorylation in homogenates of swine carotid artery. Am J Physiol 271:H776–H783
Sakurada K, Ikuhara T, Seto M, Sasaki Y (1994) An antibody for phosphorylated myosin light chain of smooth muscle: application to a biochemical study. J Biochem 115:18–21
Sato K, Hori M, Ozaki H, Takano-Ohmuro H, Tsuchiya T, Sugi H, Karaki H (1992) Myosin phosphorylation-independent contraction induced by phorbol ester in vascular smooth muscle. J Pharmacol Exp Ther 261:497–505
Seasholtz TM, Majumdar M, Brown JH (1999) Rho as a mediator of G protein-coupled receptor signaling. Mol Pharmacol 55:949–956
Seto M, Sasaki Y, Sasaki Y (1990) Stimulus-specific patterns of myosin light chain phosphorylation in smooth muscle of rabbit thoracic artery. Pflügers Arch 415:484–489
Seto M, Sasaki Y, Sasaki Y, Hidaka H (1991) Effects of HA1077, a protein kinase inhibitor, on myosin phosphorylation and tension in smooth muscle. Eur J Pharmacol 195:267–272
Sobue K, Sellers JR (1991) Caldesmon, a novel regulatory protein in smooth muscle and nonmuscle actomyosin systems. J Biol Chem 266:12115–12118
Somlyo AP, Somlyo AV (2000) Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 522:177–185
Sutton TA, Haeberle JR (1990) Phosphorylation by protein kinase C of the 20,000-dalton light chain of myosin in intact and chemically skinned vascular smooth muscle. J Biol Chem 265:2749–2754
Walsh MP, Horowitz A, Clément-Chomienne O, Andrea JE, Allen BG, Morgan KG (1996) Protein kinase C mediation of Ca2+-independent contractions of vascular smooth muscle. Biochem Cell Biol 74:485–502
Winder SJ, Walsh MP (1990) Smooth muscle calponin. Inhibition of actomyosin MgATPase and regulation by phosphorylation. J Biol Chem 265:10148–10155
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shimomura, E., Shiraishi, M., Iwanaga, T. et al. Inhibition of protein kinase C-mediated contraction by Rho kinase inhibitor fasudil in rabbit aorta. Naunyn-Schmiedeberg's Arch Pharmacol 370, 414–422 (2004). https://doi.org/10.1007/s00210-004-0975-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-004-0975-9